Background

Teva Pharmaceutical Industries Ltd., is among the top 20 pharmaceutical
companies in the world and the leader in generic pharmaceuticals, specializing
in development, production and marketing of a wide range of generic, innovative
and branded pharmaceuticals, biogenerics and active pharmaceutical
ingredients. Teva currently operates in over 60 countries with some 38,000
employees worldwide. Its innovative R&D efforts focus on therapies for the
Central nervous system (with emphasis on multiple sclerosis), autoimmune diseases and oncology. Teva differentiates itself by balancing its portfolio with
generic, innovative and branded products, vertically integrating its
pharmaceutical and API activities, combining local customer responsiveness
with a "global edge", and by its global footprint. Teva's success lies in the
leadership of its management, the skills and devotion of its people, the quality of its offerings and its focus on customers and patients.

Company Overview

• Founded in 1901
• 38,000 employees worldwide
• Annual sales are approximately $13.9 billion
• Headquartered in Petach Tikva, Israel.
• Operations in over 60 countries
• Net worth of over $ 51 billion
• Among the top 20 pharmaceutical companies and is the largest generic pharmaceutical company in the world

Contact information:
http://www.teva.co.il/